Bio Essence Statistics
Total Valuation
Bio Essence has a market cap or net worth of 19.65 million. The enterprise value is 21.21 million.
| Market Cap | 19.65M |
| Enterprise Value | 21.21M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Essence has 38.01 million shares outstanding.
| Current Share Class | 38.01M |
| Shares Outstanding | 38.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 90.49% |
| Owned by Institutions (%) | n/a |
| Float | 3.61M |
Valuation Ratios
The trailing PE ratio is 21.93.
| PE Ratio | 21.93 |
| Forward PE | n/a |
| PS Ratio | 10.36 |
| PB Ratio | -9.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.52 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 23.67 |
| EV / Sales | 11.18 |
| EV / EBITDA | 22.52 |
| EV / EBIT | 23.57 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.66 |
| Debt / FCF | n/a |
| Interest Coverage | 411.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 159.92% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -44.63% |
| Weighted Average Cost of Capital (WACC) | 55.75% |
| Revenue Per Employee | 948,783 |
| Profits Per Employee | 448,099 |
| Employee Count | 2 |
| Asset Turnover | 5.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bio Essence has paid 800 in taxes.
| Income Tax | 800 |
| Effective Tax Rate | 0.09% |
Stock Price Statistics
The stock price has increased by +118.45% in the last 52 weeks. The beta is 10.17, so Bio Essence's price volatility has been higher than the market average.
| Beta (5Y) | 10.17 |
| 52-Week Price Change | +118.45% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 83.76 |
| Average Volume (20 Days) | 17,212 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.52 |
Income Statement
In the last 12 months, Bio Essence had revenue of 1.90 million and earned 896,197 in profits. Earnings per share was 0.02.
| Revenue | 1.90M |
| Gross Profit | 1.43M |
| Operating Income | 900,011 |
| Pretax Income | 896,997 |
| Net Income | 896,197 |
| EBITDA | 900,246 |
| EBIT | 900,011 |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 1.56M |
| Net Cash | -1.56M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -2.07M |
| Book Value Per Share | -0.05 |
| Working Capital | -2.02M |
Cash Flow
| Operating Cash Flow | 1.57M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 235 |
| Net Borrowing | -1.57M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.28%, with operating and profit margins of 47.43% and 47.23%.
| Gross Margin | 75.28% |
| Operating Margin | 47.43% |
| Pretax Margin | 47.27% |
| Profit Margin | 47.23% |
| EBITDA Margin | 47.44% |
| EBIT Margin | 47.43% |
| FCF Margin | n/a |
Dividends & Yields
Bio Essence does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.56% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bio Essence has an Altman Z-Score of -24.31 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.31 |
| Piotroski F-Score | 7 |